Bisacodyl
Bisacodyl.JPG

Bisacodyl

CLINICAL USE

Laxative

DOSE IN NORMAL RENAL FUNCTION

Oral: 5–10 mg at nightRectal: 10 mg in the morningBowel evacuation:
  • 10 to 20     : mg orally at night followed by 10 mg as suppositories the next morning

    PHARMACOKINETICS

  • Molecular weight                           :361.4
  • %Protein binding                           :Negligible
  • %Excreted unchanged in urine     : 30
  • Volume of distribution (L/kg)       :
  • half-life – normal/ESRD (hrs)      :

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Unknown dialysability. Dose as in normal renal function
  • HD                     :Unknown dialysability. Dose as in normal renal function
  • HDF/high flux   :Unknown dialysability. Dose as in normal renal function
  • CAV/VVHD      :Unknown dialysability. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugsNone known

    ADMINISTRATION

    Reconstition

    Route

    Oral, rectal

    Rate of Administration

    Comments

    OTHER INFORMATION

  • Absorption is <5% orally or rectally
  • Rapidly converted in the gut (by intestinal and bacterial enzymes) to its active, but non-absorbed, desacetyl metabolite



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs